<DOC>
	<DOCNO>NCT00836355</DOCNO>
	<brief_summary>The purpose study investigate whether enoxaparin , minocycline , medication combination may help recovery acute stroke . Enoxaparin ( brand name Lovenox® ) medication approve use human prevent treat blood clot deep vein certain specific medical situation . Minocycline ( brand name Minocin® ) tetracycline antibiotic approve treat number bacterial infection human . The investigator study medication acute human stroke separately show reduce amount injured brain tissue rat make acute ischemic stroke experimentally . In human trial compare minocycline placebo ( sugar pill ) acute ischemic stroke patient take minocycline well recovery 1 week , 1 month 3 month patient take placebo .</brief_summary>
	<brief_title>Enoxaparin and/or Minocycline Acute Stroke</brief_title>
	<detailed_description>Enoxaparin low molecular weight heparin ( average molecular weight 4,500 dalton , vs. 12,000 15,000 dalton unfractionated heparin ) administer subcutaneously intravenously . It market drug FDA-approved various clinical situation : prevention treatment deep vein thrombosis ; treatment acute myocardial infarction . Minocycline orally administer antibiotic tetracycline class . It market drug FDA-approved treatment various bacterial rickettsial infection . Both medication find neuroprotective experimental stroke model . Minocycline show promise human acute stroke study . This study design investigate two logistically simple treatment regimen , singly combination , employ medication acute ischemic stroke : 1. pulse intravenous ( iv ) administration enoxaparin initiate within 6 hour complete 24 hour stroke onset ; 2. oral minocycline treatment daily five day . The goal treatment neuroprotection : limitation loss brain tissue follow ischemic stroke .</detailed_description>
	<mesh_term>Stroke</mesh_term>
	<mesh_term>Ischemia</mesh_term>
	<mesh_term>Minocycline</mesh_term>
	<criteria>There two Study Sections : A B Study Section A 1. acute ischemic stroke adult inpatient complete screen begin study treatment within 6 hour stroke onset ( onset time define last time patient know his/her usual level function ) 2. patient candidate rTPA treatment treatment start within require 3 hour stroke onset , rTPA treatment refuse . Study Section A 1. intracranial hemorrhage ; 2. subfalcine , transtentorial , foramen magnum herniation CT MRI scan brain ; 3. history hypersensitivity intolerance toxicity enoxaparin , heparinoids , heparin , minocycline , tetracycline ; 4. weight 125lbs less ; 5. active bleeding ; 6. thrombolytic treatment major surgery previous 24 hour ; 7. anticipate need treatment coumarin , lowmolecular weight heparin enoxaparin , unfractionated heparin 36 hour stroke onset ( see deep venous thrombosis prophylaxis , ) ; 8 . INR normal range ; 9. know coagulopathy ; 10. platelet count &lt; 100,000/mm3 ( count drop 100,000 enoxaparin , medication stop ) 11. pregnancy lactation ; 12. undergoing dialysis ; severe renal impairment ( creatinine clearance know estimate &lt; 30ml/min ) ; 13. mean arterial BP ( take 1/3 difference mm Hg diastolic BP systolic BP , add diastolic BP ) 130 mm Hg great ; ( mean arterial BP 130 mm Hg great reduce treatment &lt; 130 mm Hg , systolic BP 150 169 mm Hg range , patient may enter ) . Patients Study Section A randomly assign one four treatment arm : enoxaparin , minocycline , enoxaparin minocycline , intervention . Study Section B 1. acute ischemic stroke adult inpatient complete screen begin study treatment within 24 hour stroke onset ( onset time define last time patient know his/her usual level functioning ; ) 2. patient qualify , decline participate , Study Section A . Study Section B 1. acute primary intracranial hemorrhage ; 2. subfalcine , transtentorial , foramen magnum herniation CT MRI scan brain ; 3. pregnancy lactation . Patients Study Section B randomly assign one TWO treatment arm : minocycline , intervention .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>95 Years</maximum_age>
	<verification_date>March 2016</verification_date>
	<keyword>stroke</keyword>
	<keyword>magnetic resonance imaging</keyword>
	<keyword>enoxaparin</keyword>
	<keyword>minocycline</keyword>
	<keyword>NIH stroke scale</keyword>
	<keyword>modify Rankin scale</keyword>
	<keyword>neuroprotection</keyword>
</DOC>